Page last updated: 2024-08-05 12:44:39
rolipram
A member of the lclass of pyrrolidin-2-ones that is pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor.
ChEBI ID: 104872
Members (2)
| Member | Definition | Role |
|---|---|---|
| (+)-rolipram | The (S)-enantiomer of rolipram. | (+)-rolipram |
| rolipram | The (R)-enantiomer of rolipram. | (-)-rolipram |
Research
Studies (28)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 6 (21.43) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 36 (100.00%) | 84.16% |